Galena Biopharma -17% after report rips painkiller drug sample giveaway

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE -16.9%) plunges after Bronte Capital's John Hempton ridicules the company for marketing its fentanyl-based painkiller Abstral with free samples - "a new low in the pharmaceutical industry."

GALE's giveaway is "evil," Hempton writes; it's "doing hippie alternative lifestyle drug marketing for drugs that are especially effective in turning you into a zombie."

Adam Feuerstein reminds investors that when examining Q4 and 2013 results, "market share gains derived from free samples don't mean much."

Matt Gravitt recently posted his own negative critique on SA, highlighting "numerous red flags" which suggest a "significant overvaluation."